CustoMed
Transforming Surgery Excellence with 3D-printed Patient-specific Instruments at Scale
Company Overview
Snapshot
Founded in October 2023, CustoMed operates with 1–10 employees. The company has raised $6M across one funding round from 5 investors. In October 2025, CustoMed announced $6M in funding to scale its AI-powered 3D-printed solutions for orthopedic surgery.
Business overview
CustoMed develops an automation platform leveraging AI-powered segmentation to convert CT scans into detailed 3D anatomical models. This technology provides surgeons with an intuitive interface for fine-tuning surgical plans and patient-specific instrument (PSI) designs, ensuring optimal customization. The platform also includes an integrated case manager and a comprehensive library of procedures and hardware for hospitals, streamlining case management. CustoMed's computer-generated PSIs are optimized for immediate printing, enhancing surgical excellence in the medical devices and assistive devices sectors.
Strategic signal
In October 2025, CustoMed announced $6M in funding to scale its AI-powered 3D-printed solutions for orthopedic surgery. This investment signals strong market validation for CustoMed's innovative approach to surgical planning and instrument design, indicating a significant step towards broader adoption of its technology within the orthopedic surgery market and a potential for accelerated product development and market expansion.
Log in to access full profile ›Company Intelligence Q&A
- What is CustoMed's core technology?
- CustoMed's core technology is an automation platform equipped with AI-powered segmentation that converts CT scans into detailed 3D anatomical models, enabling precise fine-tuning of surgical plans and patient-specific instrument (PSI) designs.
- When was CustoMed founded?
- CustoMed was founded in October 2023.
- What funding did CustoMed announce in October 2025?
- In October 2025, CustoMed announced $6M in funding to scale its AI-powered 3D-printed solutions for orthopedic surgery. Investors included Avishai Abrahami and Flag Capital.
- What problem does CustoMed's solution address for hospitals?
- CustoMed's platform provides hospitals with an integrated case manager and a vast library of procedures and hardware, facilitating seamless case management and optimizing computer-generated patient-specific instruments for immediate printing.
- Which sectors does CustoMed operate in?
- CustoMed operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Assistive Devices, utilizing Artificial Intelligence and Materials & Substances technologies.